Company / Gross Margin
Solventum Gross Margin History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
53.5%
FY2025
5-year range
53.5% / 57.7%
FY2022-FY2025
Trend
-3.9%
vs FY2024
Sector context
#57 of 96
Health Care
What the data says
At 53.5%, Solventum's gross margin ranks #57 of 96 in the Health Care sector. Gross Margin has declined for 3 consecutive years, from 57.7% in FY2022 to 53.5% in FY2025.
Based on SEC 10-K filings.
53.5% in FY2025 with a 3-year CAGR of -4.3%.
Declined from 57.3% to 53.5% over the past 2 years.
Health Care sector context is included.
Gross Margin over time
Growth rates
- 3-Year Change
- -4.3pp
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
In line with sector averageTop 59% of 96This company 53.5% Sector average 53.6%
▼
In line with sector average
Key checks
Key Insights
- Solventum's gross margin has declined for 3 consecutive years.
- In FY2025, gross margin decreased 3.9% year-over-year.
- Currently 0.1pp below the Health Care sector average.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
- Strong return on equity: 30.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 53.5% | -3.9% |
| FY2024 | 55.6% | -2.8% |
| FY2023 | 57.3% | -0.9% |
| FY2022 | 57.7% | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026